These recommendations were systematically developed on behalf of the Network for Early
Onset Cystic Kidney Disease (NEOCYST) by an international group of experts in autosomal …

Polycystic liver disease (PLD) is a rare hereditary disease that independently exists in
isolated PLD, or as an accompanying symptom of autosomal dominant polycystic kidney …

The advent of enhanced radiological imaging techniques has facilitated the diagnosis of
cystic liver lesions. Concomitantly, the evidence base supporting the management of these …

Autosomal-dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause
of end-stage renal disease in adults. Affected individuals and families face a significant …

Autosomal dominant polycystic kidney disease (ADPKD) is a chronic, progressive condition
characterized by the development and growth of cysts in the kidneys and other organs and …

Distinguishing autosomal‐dominant polycystic kidney disease (ADPKD) from other inherited
renal cystic diseases in patients with adult polycystic kidney disease and no family history is …

Background Enterococcus casseliflavus is a rare pathogenic bacterium that is characterized
by vancomycin resistance and can lead to multiple infections in the human body. This report …

Cystic kidney diseases affect patients of all age groups with the onset spanning from
prenatal disease to late adulthood. Autosomal-dominant polycystic kidney disease (ADPKD) …

Polycystic liver disease (PLD) is a rare genetic disorder with progressive cyst growth as the
primary phenotype. Therapy consists of volume reduction through invasive surgical or …

Autosomal dominant polycystic kidney disease (ADPKD) occurs uniformly throughout the
world. ADPKD has high intrafamilial and interfamilial heterogeneity due to environmental …